Alignment Healthcare (ALHC) Current Deferred Revenue (2021 - 2023)
Alignment Healthcare's Current Deferred Revenue history spans 3 years, with the latest figure at $146.3 million for Q3 2023.
- For Q3 2023, Current Deferred Revenue rose 25.33% year-over-year to $146.3 million; the TTM value through Sep 2023 reached $146.3 million, up 25.33%, while the annual FY2022 figure was $308000.0, 34.33% down from the prior year.
- Current Deferred Revenue reached $146.3 million in Q3 2023 per ALHC's latest filing, down from $147.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $147.5 million in Q2 2023 to a low of $308000.0 in Q4 2022.
- Average Current Deferred Revenue over 3 years is $92.1 million, with a median of $128.9 million recorded in 2022.
- Peak YoY movement for Current Deferred Revenue: plummeted 34.33% in 2022, then rose 25.33% in 2023.
- A 3-year view of Current Deferred Revenue shows it stood at $469000.0 in 2021, then tumbled by 34.33% to $308000.0 in 2022, then soared by 47413.64% to $146.3 million in 2023.
- Per Business Quant, the three most recent readings for ALHC's Current Deferred Revenue are $146.3 million (Q3 2023), $147.5 million (Q2 2023), and $141.1 million (Q1 2023).